Primordial germ cells from chicken embryonic stem cells
来自鸡胚胎干细胞的原始生殖细胞
基本信息
- 批准号:6833398
- 负责人:
- 金额:$ 16.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-12-15 至 2005-06-14
- 项目状态:已结题
- 来源:
- 关键词:artificial chromosomesbiotechnologybiotherapeutic agentbone morphogenetic proteinschickensembryonic stem cellflow cytometrygenetically modified animalsgerm cellsgreen fluorescent proteinsimmunocytochemistrymixed tissue /cell culturemonoclonal antibodytechnology /technique developmenttransfection /expression vector
项目摘要
DESCRIPTION(provided by applicant): At Origin Therapeutics we have derived chicken embryonic stem cells (cES) that can be maintained in culture for extended periods of time and contribute extensively to the somatic tissues in chimeras and at low levels to the germline. Origin's goal is to use these cES cells to create transgenic chickens producing clinically relevant pharmaceutical proteins in their eggs. Origin has established routine procedures for stable transfection of ES cells with constructs up to 160 kb and has produced chimeras with ES cells carrying a 45 kb transgene that encodes the production of the heavy and light chain components of a human monoclonal antibody. This monoclonal antibody is expressed exclusively in the tubular gland cells of the oviduct and is exported into egg white. For optimal production of proteins fully transgenic chickens are required necessitating robust germline transmission. In recent years differentiated somatic cells have been derived from human and murine ES cells. Most recently oocytes and sperm have also been derived from mouse ES cells. In the chicken PGCs migrate to the gonads through the vasculature. Exogenous PGCs, when injected at the appropriate time, can substantially colonize the germline of recipient embryos. To obtain robust levels of germline transmission this application proposes to derive PGCs from embryonic stem cells and to colonize the gonad with in vitro derived PGCs.
描述(由申请人提供):在Origin Therapeutics,我们已经获得了鸡胚胎干细胞(cES),这些细胞可以在培养物中保持较长的时间,并在嵌合体中广泛参与体细胞组织,并在低水平下参与种系。Origin的目标是利用这些cES细胞来创造转基因鸡,在鸡蛋中产生临床相关的药物蛋白。Origin已经建立了用高达160 kb的构建体稳定转染ES细胞的常规程序,并且已经用携带45 kb转基因的ES细胞产生嵌合体,所述45 kb转基因编码人单克隆抗体的重链和轻链组分的产生。该单克隆抗体仅在输卵管的管状腺细胞中表达,并输出到卵白色中。为了最佳生产蛋白质,需要完全转基因的鸡,这需要强大的种系传播。近年来,分化的体细胞已经从人和鼠ES细胞中衍生出来。最近,卵母细胞和精子也来源于小鼠ES细胞。在鸡中,PGCs通过脉管系统迁移到性腺。当在适当的时间注射外源性PGCs时,可以基本上定殖受体胚胎的生殖系。为了获得稳健水平的生殖系传递,本申请提出从胚胎干细胞衍生PGC,并用体外衍生的PGC定殖性腺。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIE-CECILE VAN DE LAVOIR其他文献
MARIE-CECILE VAN DE LAVOIR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIE-CECILE VAN DE LAVOIR', 18)}}的其他基金
Production of germline competent chicken cell lines
鸡种系感受态细胞系的生产
- 批准号:
6883508 - 财政年份:2005
- 资助金额:
$ 16.39万 - 项目类别:
Production of germline competent chicken cell lines
鸡种系感受态细胞系的生产
- 批准号:
7126996 - 财政年份:2005
- 资助金额:
$ 16.39万 - 项目类别:
Production of germline competent chicken cell lines
鸡种系感受态细胞系的生产
- 批准号:
7106249 - 财政年份:2005
- 资助金额:
$ 16.39万 - 项目类别:
Transgenic Chickens using Primordial Germ Cells
使用原始生殖细胞的转基因鸡
- 批准号:
7054360 - 财政年份:2005
- 资助金额:
$ 16.39万 - 项目类别:
Transgenic Chickens using Primordial Germ Cells
使用原始生殖细胞的转基因鸡
- 批准号:
7239620 - 财政年份:2005
- 资助金额:
$ 16.39万 - 项目类别:
Transgenic Chickens using Primordial Germ Cells
使用原始生殖细胞的转基因鸡
- 批准号:
7382893 - 财政年份:2005
- 资助金额:
$ 16.39万 - 项目类别:
相似海外基金
Pioneering reproductive biotechnology innovations for equine breeding
开创马匹育种生殖生物技术创新
- 批准号:
LP230100156 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Linkage Projects
Industrial Biotechnology Innovation Cluster
产业生物技术创新集群
- 批准号:
EP/Y024168/1 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Research Grant
Environmental Biotechnology Innovation Centre
环境生物技术创新中心
- 批准号:
BB/Y008332/1 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Research Grant
Shear Innovation: Valorising wool waste using biotechnology to enhance horticultural peat-free growing media
剪切创新:利用生物技术提高羊毛废料的价值,以增强园艺无泥炭生长介质
- 批准号:
10106787 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Launchpad
Conference: Translating Molecular Science Innovations into Biotechnology Solutions
会议:将分子科学创新转化为生物技术解决方案
- 批准号:
2419731 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Standard Grant
MFB: Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology: Stabilizing Hairpin Inserts in RNA Virus Induced Gene Silencing Vectors
MFB:合作变革新兴产业 - RNA 工具/生物技术:稳定 RNA 病毒诱导基因沉默载体中的发夹插入
- 批准号:
2330663 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Standard Grant
I-Corps: Translation potential of a miniaturized biotechnology platform for nucleic acid extraction, purification, and library preparation
I-Corps:用于核酸提取、纯化和文库制备的小型生物技术平台的转化潜力
- 批准号:
2421022 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Standard Grant
NSF Convergence Accelerator Track M: Biofilm-based Corrosion Control using 3D Printed Biotechnology
NSF 融合加速器轨道 M:使用 3D 打印生物技术进行基于生物膜的腐蚀控制
- 批准号:
2344389 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Standard Grant
Engineering Biology Hub for environmental processing and recovery of metals; from contaminated land to industrial biotechnology in a circular economy
用于环境处理和金属回收的工程生物中心;
- 批准号:
BB/Y008456/1 - 财政年份:2024
- 资助金额:
$ 16.39万 - 项目类别:
Research Grant
Conference: 2023 Chloroplast Biotechnology GRC & GRS: Harnessing the SynBio Revolution for Metabolic Engineering and Enhanced Photosynthesis
会议:2023年叶绿体生物技术GRC
- 批准号:
2243932 - 财政年份:2023
- 资助金额:
$ 16.39万 - 项目类别:
Standard Grant